Target intelligence / Profile preview

Neural tissue repair

Molecular classification
Other
01

Overview

"Neural tissue repair" is not a single molecule or receptor but rather an umbrella term describing the complex biological processes that restore structure and function after nervous system injury. This includes mechanisms such as neurogenesis, axon regrowth, synaptic remodeling, remyelination by oligodendrocytes, and modulation of inhibitory factors like chondroitin sulfate proteoglycans and myelin-associated proteins. Key molecular players include neurotrophic factors (such as BDNF acting via TrkB), inhibitors like Nogo-A interacting with NgR1/p75/TROY/LINGO1 receptors, extracellular matrix components influencing glial scar formation (e.g., keratan sulfate proteoglycans), and various guidance molecules such as ephrins and semaphorins. Therapeutic strategies aim to enhance endogenous regenerative capacity by promoting beneficial signaling pathways while inhibiting those that restrict regrowth. Because "neural tissue repair" refers to a set of processes rather than a discrete druggable target molecule or receptor, it is not considered a canonical therapeutic target itself but encompasses many potential targets within its scope[1][2][3].

Other names
Neural tissue regenerationNeuroregenerationNeural repairNerve regeneration
02

Mechanism of action

Promotion of neurotrophic signaling (e.g., BDNF-TrkB pathway); Inhibition of axonal growth inhibitors (e.g., antagonists to Nogo-A/NgR1 pathway); Modulation of extracellular matrix components to reduce glial scarring.

03

Biological functions

Neuronal plasticityAxon regenerationSynapse formationMyelin repairGlial scar modulation
04

Disease associations

Neurodegenerative diseaseSpinal cord injuryMultiple sclerosisTraumatic brain injury
05

Safety considerations

Off-target effects due to broad modulation of neuronal growth and plasticity.Risk of aberrant sprouting or tumorigenesis if stem cell-based approaches are used.Immune response complications with regenerative therapies
06

Interacting drugs

Neuroprotective agents (general class)
07

Biomarkers

None specific for "neural tissue repair" as a target; biomarkers are typically related to underlying molecular pathways or cell types involved in the process.

Beyond the preview

Go deeper on Neural tissue repair.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neural tissue repair.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call